1. Moghadasian MH, Mcmanus BM, Godin DV, Rodrigues B, Frohlic JJ. Proatherogenic and antiatherogenic effects of probucol phytosterols in apoliprotein E-deficient mice. Circulation 1999; 99: 1733-1739.
2. Steinberg D, Parthasarathy S, Thomas EC, John CK, and Joseph LW. Beyond cholesterol modifications of Low-Density Lipoprotein That Increase it’s Atherogenicity. The New England Journal of Medicine 1989; 320: 915-924.
3. Regnstrom J, Nilsson J. Lipid oxidation and inflammation-induced intimal fibrosis in Coronary heart disease. Journal of Laboratory & Clinical Medicine 1994; 124: 162-168.
4. Aldons J. Atherosclerosis. Nature 2000; 407: 233-241.
5. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow SR, Lithgow GJ. Extension of life-span with superoxide dismutase/catalase mimetics. Science 2000 ;289:1567-1569.
6. Scoott MG. The role of cholesterol management in coronary disease risk reduction in elderly patients. Endocrinology and Metabolism Clincs of North America 1998; 23: 655-675.
7. Robert A. Hegele. Pathogenesis of atherosclerosis. Clinica Chimica Acta 1996;246:21-38.
8. Bergendi L., Benes L., Durackova Z., Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sciences 1999; 65:1865-1874.
9. Barbouti A, Doulias PT, Zhu BZ, Frei B, Galaris D. Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radical Biology and Medicine 2001 ; 31:490-498.
10. Jun L. Manganese Superoxide dismutase. B-180 Medical Laboratories Free Radical and Radiation Biology Program 2001;77:1-10
11. Fridovich I. The biology of oxygen radicals. Science 1978; 201: 875-880.
12. Walling C. In oxidase and realated redox systems. Pergamon Press, Oxford 1982; 85-97.
13. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1448.
14. Francisco BM, Alicia S, Manuel DL, Francisco R. Lipid peroxidation products in human subretinal fluid. Free Radical Biology and Medicine 1996; 20: 899-903.
15. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991 ;349:431-434.
16. Deiana M, Halliwell B, John MC.Gutteridge. Inhibition of peroxynitrite dependent DNA base modification and tyrosine nitration by the extra virgin olive oil-derived antioxidant hydroxytyrosol.Free Radical Biology and Medicine 1999;26:762-769.
17. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA.8- Hydroxyguanine, an abundant form of oxidative DNA damage, cause G _ T and A _ C substitution. J Biol Chem 1992; 267: 166-172.
18. Dizdaroglu M. Oxidative damage to DNA in mammalian chromation. Mutat Res 1992; 275: 331-342
19. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 2002;37:56-62.
20. Loft S., Fischer-Nielsen A., Jeding I.B., Vistisen K.and Poulsen H.E. 8-Hydroxydeoxyguanosine As Urinary Biomarker of Oxidative DNA Damage. Journal of Toxicology and Environmental Health 1993; 40: 391-404.
21. Fraga C.G., Shigenaga M.K., Park J.W., Degan P.and Ames B.N. Oxidative damage to DNA during aging:8-hydroxy-2''- deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990; 87: 4533-4537.
22. Sai K., Takagi A., Umemura T., Hasegawa R. and Kurokawa Y. Changes of 8-hydroxydeoxyguanosine levels in rat organ DNA during the aging process. Journal of Environmental Pathology and Oncology 1992; 11: 139-143.
23. Hayakawa M., Torii K., Sugiyama S., Tanaka M.and Ozawa T. Age- associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm. Biochemical and Biophysical Research Communications 1991; 179: 1023-1029.
24. Randerath K, Zhou GD, Monk SA and Randerath E. Enhanced levels in neonatal rat liver of 7’8-dihydro-8-oxo-2’-deoxyguanosine (8-hydroxydeoxyguanosine) a major mutagenic oxidative DNA. Carcinogenesis 1997;18:1419-1421
25. Lodovici M, Casalini C, Cariaggi R, Michelucci L, Dolara P. Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes.Free Radical Biology and Medicine 2000; 28: 13-17.
26. Loft S, Vistisen K, Ewertz M, Overvad K and Poulsen HE, Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking , gender and bodymass index. Carcinogenesis 1992; 13: 2241-2247.
27. Albert A. van Zeeland, Anton JL. de Groot, Janet Hall, Francesco Donato. 8-Hydroxydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutation Research 1999; 439: 249-257.
28. Kiyosawa H, Suko M, Okudaira H, Murata K, Miyamoto T, Chung M.H, Kasai H and Nishimura S. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damage in human peripheral leukocyte. Free Redical Research Communications 1990; 11: 23-27.
29. Nakajima M. Takeuchi T, Takeshita T and Morimotok. 8- hydroxydeoxyguanosine in human leukocyte DNA and daily health practice facters: effects of individual alcohol sensitivity. Environmental Health Perspectives 1996; 104: 1336-1338.
30. Inoue T, Mu Z, Sumikawa K, Adachi K and Okochi T. Effect of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA repared from human lymphocytes. Japanese Journal of Cancer Research 1993; 84: 720-725.
31. Pilger A,Germadnik D, Formanek D, Zwick H, Winkler N and Rudiger HW. Habitual long-distance running dose not enhance urinary excretion of 8-hydroxydeoxyguanosine. European Journal of Applied Physiology and Occupational Physiology 1997; 75: 467-469.
32. Tsai K, Hsu TG, Hsu KM, Cheng H, Liu TY, Hsu CF, and Kong CW, Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise, Free Radical Biology & Medicine.2001;31:1465-1472.
33. Simic MG and Bergtold DS. Dietary modulation of DNA damage in human.Mutation Research 1991;250:17-24.
34. Cho SH, Im JG, Choi YS and Chung MH. Lipid peroxidation and 8-hydroxydeoxyguanosine formation in rats fed fish oil with different levels of vitamin E. Journal of Nutritional Science and Vitaminology 1995;41:61-72.
35. Lee BM, Lee SK, Kim HS. Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, β-carotene and red ginseng). Cancer Letters 1998；132：219-227.
36. Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K, and Jaruga P. Oxidative DNA damage:assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radical Biology and Medicine 2002 ;33:192-200.
37. Jaruga P, Jaruga B, Gackowski D, Olczak A, Halota W, Pawlowska M, Olinski R. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radical Biology and Medicine 2002 ;32:414-420.
38. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Research 1994; 54: 3171-3172.
39. Ni ZY, Liu YQ, Shen HM, China SE and Dug CN. Pose the increase of 8-hydroxydeoxyguanosine lead to poor sperm quality. Mutation Research 1997;381:77-82.
40. Tsuboi H, Kouda K, Takenchi H, Takigawa M, Masamoto Y, Takeuchi M and Ochi H. 8-hydroxydeoxyguanosine in urine as an index of oxidative damage to DNA in the evalution of atopic dermatitis. British Journal of Dermatology 1998;138:1033-1035.
41. Inoue M, Osaki T, Noguchi M, Hirohashi S Yasumoto K and Kasai H. Lung cancer patients have increase 8-hydroxydeoguanosine levels in peripheral lung tissue DNA. Japanese Journal of Cancer Research 1998;89:691-695.
42. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nahashima H, Omae K, Watanabe M, Hibi T, Kitajima M. Increased formation of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Letters 2000; 151: 87-95.
43. Park KS, Kim MS, Kim JM, Kim SK, Choi JY, Chung MH, Han B, Kim SY, Lee HK. Effects of Insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxy- guanosine in streptozotocin-induced Diabetic rats. Diabetes 2001; 50:2837-2841.
44. Jikimoto T, Nishikubo Y, Koshiba M, Kanagawa S, Morinobu S, Morinobu A, Saura R, Mizuno K, Kondo S, Toyokuni S, Nakamura H, Yodoi J, Kumagai S. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Molecular Immunology 2001;38:765-772.
45. Wei H, Zhang X, Wang Y, Lebwohl M. Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Letters 2002;185:21-29.
46. Weisburger JH, Chung FL. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food and Chemical Toxicology 2002;40:1145-1154.
47. Wolf FI, Torsello A, Covacci V, Fasanella S, Montanari M, Boninsegna A, Cittadini A. Oxidative DNA damage as a marker of aging in WI-38 human fibroblasts. Experimental Gerontology 2002;37:647-656.
48. Steinbrecher UP, Zhang H, Lougheed, M. role of oxidatively modified LDL in atherosclerosis. Free Radical Biology and Medicine 1990; 9: 155-168.
49. Chen KH, Srivastava DK, Singhal RK, Jacob S, Ahmed AE, Wilson SH. Modulation of base excision repair by low density lipoprotein, oxidized low density lipoprotein and antioxidants in mouse monocytes. Carcinogenesis 2000 ;21:1017-22.
50. Jessup W, Rankin SM, De Whalley CV, Hoult JRS, Scott J, Leake DS. Alpha-tocopherol consumption during low-density lipoprotein oxidation. Biochem Journal 1990; 265: 399-405.
51. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
52. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein b in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990; 10: 336-349.
53. Inoue T, Inoue K, Maeda H, Takayanagi K, Morooka S. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clinica Chimica Acta 2001;305:115-121.
54. Gackowski D, Kruszewski M, Jawien A, Ciecierski M, and Olinski R. Further evidence that oxidative stress may be a risk factor responsible for the development of atherosclerosis. Free Radical Biology and Medicine 2001;31:542-547.
55. 李建武、蕭能庚、余瑞元、陳麗蓉、陳雅蕙、陳來同、袁明秀，生物化學實驗原理和方法。藝軒出版社1999年1月。
56. 吳健三，高效液相層析儀 (實務編)。建吾企業股份有限公司 1996年2月。
57. Friedberg, EC, Walker GC, and Siede W. DNA repair and mutagenesis. Washington, D.C.ASM Press, 1995, 1-698.
58. Robert F. Weaver. Molecular Biology. Mc Graw Hill 2002, 671-676.
59. Roth DB, Gellert M. New guardians of the genome. Nature 2000; 404 :823-825.
60. Martinet W, Michiel W.M. Knaapen, Guido R.Y. De Meyer, Arnold G. Herman, Mark M. Kockx. Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering. Circ Res. 2001;88:733-739.
61. Martinet W, Michiel W.M. Knaapen, Guido R.Y. De Meyer, PharmD, Arnold G. Herman, Mark M. Kockx. Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques. Circulation. 2002;106:927-932.
62. Tabas I. P53 and Atherosclerosis. Circulation Research. 2001; 88: 747-749.
63. Guevara NV, Kim HS, Antonova EI, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nature medicine 1999; 5: 335-339.
64. Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, Nakata Y, Kutsumi Y, Ohshima S, Nishiyama S, Seki A, Kato K, Nishimura S, Kanoh T, Yamaguchi H. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol 1997;30:855-62.
65. Wagberg M, Eriksson AW, Pettersson K. Effects of probucol on aortic and coronary atherosclerosis in young, adolescent and old WHHL rabbits. Atherosclerosis 1997;134:41.
66. Itoh H, Komori K, Sugimachi K. Effect of Probucol on Intimal Hyperplasia of Autologous Vein Graft in Hyperlipidemic Rabbits. Cardiovascular surgery. 1995;3:26.
67. Steinberg D, Parthasarathy S, Carew TE. In vivo inhibition of foam cell development by probucol in Watanabe rabbits. Am J Cardiol 1988 ;62:6B-12B.
68. Zhou Qi, Kummerow FA. Antioxidative effects of lovastatin in cultured human endothelial cells. J Nutr Biochem 2002 ;13:200-208.
69. Auerbach BJ, Krause BR, Bisgaier CL, Newton RS. Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin. Atherosclerosis 1995 ;115:173-80.
70. Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 1997 ;30:569-75.
71. Zhu BQ, Sievers RE, Sun YP, Isenberg WM, Parmley WW. Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits. J Cardiovasc Pharmacol 1992 ;19:246-55.
72. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U.S.A. 1987 ;84:7725-9.
73. 張賢哲、黃桂花等，中藥炮製學。中國醫藥學院 1995; 110-111、283-285、209-212、323-324、457-459。
74. 林景彬，常用中藥藥理與應用 (一)。1997; 519-525。
75. 劉新裕等，Proceedings of the symposium on development and utilization of medicinal plasnts. Taiwan Agricural Research Institute 1999; 87: 1-17。
76. 謝明村等，中國藥材學。1995; 559-562。
77. Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation 1995 ;91:776-784.
78. Yamakoshi J, Kataoka S, Koga T, Ariga T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 1999 ;142:139-149.
79. Yang M, Chen K, Shih1t C. Yang-Gan-Wan protects Mice again apoptosis induced by anti-Fas antibody (Jo2). American Journal of Chinese Medicing, 2000;28: 325-330.
80. Chen JW. Effects of Rhizoma Ligustici chuanxiong and allopurinol on ischemia-reperfusion damage of rabbit ear flap. Zhonghua Wai Ke Za Zhi. 1993 ;31:312-314.
81. Wang Y, Li CY, Lin IH, Lee AR, Hu MK. Synthesis and radical scavenging of novel magnolol derivatives. J Pharm Pharmacol 2002 ;54:1697-1703.
82. Kong CW, Tsai K, Chin JH, Chan WL, Hong CY. Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 2000 ;13:24-28.
83. Huang CH, Hong CY, Tsai SK, Lai ST. Effect of magnolol on coronary vascular resistance in rabbits: measurement with pulsed Doppler velocimetry. J Formos Med Assoc 2000 ;99:554-558.
84. Chen YL, Yang SP, Shiao MS, Chen JW, Lin SJ. Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits. J Cell Biochem 2001 ;83:484-493.
85. Chen HY, Shiao MS, Huang YL, Shen CC, Lin YL, Kuo YH, Chen CC. Antioxidant principles from Ephemerantha lonchophylla. J Nat Prod 1999 ;62:1225-1227.
86. 曾悅和，山藥在高血脂兔子之抗氧化及抗粥狀動脈之影響。中國醫藥學院碩士論文2002。87. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000 ;408:433-439.
88. Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2’- Deoxyguanosine(8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leukemia Research 2000; 24: 461-468.
89. De Flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 1997;12:1021-1031.
90. Thompson HJ, Haegele HA, Sedlacek SM, Gillette C, O’Neill C., Wolfe P, Conry C. Effect of increased vegetable and fruit consumption on marker of oxidative cellular damage. Carcinogenesis 2000;20:2261-2266.
91. Zhu CQ, Lam HT, Jiang CQ, Wei BX, Lou X, Liu WW, Lao XQ, Chen YH Lymphocyte DNA damage in cigarette factory workers measured by the comet assay. Mut Res. 1999;444:1-6.
92. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxydeoxyguanosine, and its repair activity in human leukocyte by cigarette smoking. Cancer Res. 1996;56:2546-2549.
93. Howard DJ, Ota RB, Briggs LA, Hamptom M, Pritsos CA. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2-deoxyguanosine. Cancer Epidemiol Biomarkers Prev 1998;7:141-146.
94. Poulsen HE, Loft S. Early biochemical markers of effects：enzyme induction, oncogene activation and markers of oxidative damage. Toxicology 1995; 101:55-64.
95. Takeuchi T, Nakjima M, Ohra Y, Mure K, Tokeshita T, Morimoto K. Evaluation of 8-hydroxydeoxyguanosine, a typical oxidative DNA damage, in human leukocytes. Carcinogenesis 1994;15:1519-1523.
96. Brown WM, Prager EM, Wang A, Wilson AC. Mitochondrial DNA sequences of primates: tempo and mode of evolution. J Mol Evol 1982;18:225-239.
97. Nagashima M, Tsuda H, Takenoshita S, Nagamachi Y, Hirohashi S, Yokota J, Kasai H. 8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett. 1995;90:157-162
98. 行政院農業委員會漁業署，行政院農委會漁業署氯黴素檢驗方法研討會報告，92年1月22日。
99. 張淑芬，鉻電鍍工廠勞工尿液中8-Hydroxy-2’-deoxyguanosine 之研究。中國醫藥學院碩士論文1999。